← All trials
NCT07059975
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2025
- Primary completion
- Oct 31, 2028
- Completion date
- Aug 31, 2031
- First posted
- Jul 11, 2025
- Last posted
- Nov 4, 2025
- Enrollment
- 36
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Baylor UniversityLead sponsor
- Baylor UniversitySponsor investigator
- Baylor UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.